10.04.2018 - By Medical Practice Trends
Daniel Medrano, CEO of DND, presents the DND, a hand-held diabetic neuropathy device for in-office evaluation. This issue (10:42): - What is the Diabetic Neuropathy Device? - What objective measurements are provided? - Why its numerical output is superior to the qualitative output of other devices - How does the DND best fit in your practice?